IL263477A - Compositions and methods for the treatment or prevention of oxalate-related disorders - Google Patents

Compositions and methods for the treatment or prevention of oxalate-related disorders

Info

Publication number
IL263477A
IL263477A IL263477A IL26347718A IL263477A IL 263477 A IL263477 A IL 263477A IL 263477 A IL263477 A IL 263477A IL 26347718 A IL26347718 A IL 26347718A IL 263477 A IL263477 A IL 263477A
Authority
IL
Israel
Prior art keywords
oxalate
prevention
compositions
treatment
methods
Prior art date
Application number
IL263477A
Other languages
English (en)
Hebrew (he)
Original Assignee
Oxthera Intellectual Property Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxthera Intellectual Property Ab filed Critical Oxthera Intellectual Property Ab
Publication of IL263477A publication Critical patent/IL263477A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL263477A 2016-06-13 2018-12-04 Compositions and methods for the treatment or prevention of oxalate-related disorders IL263477A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1650828 2016-06-13
PCT/EP2017/064422 WO2017216165A1 (en) 2016-06-13 2017-06-13 Compositions and methods for the treatment or prevention of oxalate-related disorders

Publications (1)

Publication Number Publication Date
IL263477A true IL263477A (en) 2019-01-31

Family

ID=59067657

Family Applications (1)

Application Number Title Priority Date Filing Date
IL263477A IL263477A (en) 2016-06-13 2018-12-04 Compositions and methods for the treatment or prevention of oxalate-related disorders

Country Status (12)

Country Link
US (2) US10765709B2 (https=)
EP (1) EP3468572B1 (https=)
JP (1) JP7016353B2 (https=)
CN (1) CN109641019A (https=)
AU (1) AU2017286220A1 (https=)
CA (1) CA3023042A1 (https=)
ES (1) ES2913398T3 (https=)
IL (1) IL263477A (https=)
JO (1) JOP20180110A1 (https=)
MA (1) MA45226A (https=)
TN (1) TN2018000420A1 (https=)
WO (1) WO2017216165A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders
US20210386793A1 (en) * 2018-10-04 2021-12-16 Oxthera Intellectual Property Ab New medical use of oxalate-reducing bacteria
CN110607262B (zh) * 2019-09-25 2022-03-25 君维安(武汉)生命科技有限公司 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用
EP3839039A1 (en) * 2019-12-16 2021-06-23 4D Pharma Research Limited Providing bacterial biomass with improved storage stability
BR112022013867A2 (pt) * 2020-01-14 2022-09-13 Synlogic Operating Co Inc Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial
CA3175041A1 (en) * 2020-03-10 2021-09-16 Federation Bio Inc. Microbial consortia for the treatment of disease
EP4043018A1 (en) * 2021-02-10 2022-08-17 Charité - Universitätsmedizin Berlin Composition and method for reducing oxalate levels in patients receiving maintenance dialysis
CA3216136A1 (en) * 2021-04-30 2022-11-03 Aaron Blake Cowley Compositions for preserving anaerobic microorganisms and methods of making and using the same
WO2023102091A2 (en) * 2021-12-01 2023-06-08 Federation Bio, Inc. Microbial consortia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
BG61712B1 (bg) * 1994-12-29 1998-04-30 "Ел Би Булгарикум" ЕАД закваски за българско кисело мляко и млечнокисели продукти и методи за получаването им
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
JP4996780B2 (ja) 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
WO2005097176A2 (en) 2004-03-26 2005-10-20 University Of Florida Research Foundation, Inc. Modulating oxalate transport
CA2608862C (en) 2004-06-11 2020-05-05 Trustees Of Tufts College Silk-based drug delivery system
WO2007070052A2 (en) 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
JP5193626B2 (ja) 2008-02-20 2013-05-08 日本曹達株式会社 微生物農薬製剤の保存方法
US9714456B2 (en) 2013-01-18 2017-07-25 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
EP3468572B1 (en) * 2016-06-13 2022-03-02 OxThera Intellectual Property AB Compositions and methods for the treatment or prevention of oxalate-related disorders

Also Published As

Publication number Publication date
US20190125807A1 (en) 2019-05-02
AU2017286220A1 (en) 2018-12-06
TN2018000420A1 (en) 2020-06-15
EP3468572A1 (en) 2019-04-17
WO2017216165A1 (en) 2017-12-21
CN109641019A (zh) 2019-04-16
JOP20180110A1 (ar) 2019-01-30
ES2913398T3 (es) 2022-06-02
CA3023042A1 (en) 2017-12-21
US10765709B2 (en) 2020-09-08
US20210052670A1 (en) 2021-02-25
EP3468572B1 (en) 2022-03-02
JP2019521182A (ja) 2019-07-25
MA45226A (fr) 2019-04-17
JP7016353B2 (ja) 2022-02-04

Similar Documents

Publication Publication Date Title
IL298689B1 (en) Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions
IL290150A (en) Compounds and methods for treating chronic pain
IL260352B (en) Methods and preparations for the treatment of neurological disease
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
IL266047A (en) Methods and preparations for the treatment of Fabry disease
IL264176A (en) Methods and preparations for the treatment of cancer
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
PL3448421T3 (pl) Sposoby i kompozycje do zapobiegania i leczenia zrostów chirurgicznych
ZA202002066B (en) Compositions and methods for the treatment of eye disorders
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
IL272097A (en) Compounds for the prevention and treatment of medical disorders and their uses
GB201611712D0 (en) Methods and compounds for the treatment or prevention of severe or persistent influenza
EP3261446A4 (en) Methods and compositions for the treatment or prevention of parkinson's disease
PL3122367T3 (pl) Kompozycje na bazie szafranu do zapobiegania i/lub leczenia chorób zwyrodnieniowych oka
ZA201808232B (en) Compositions and methods for the treatment of cancer
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
ZA201900984B (en) Methods and compositions for the treatment of warts
IL262479A (en) Methods and formulations for treatment and/or prevention of blood-associated disorders
IL282455A (en) Methods and preparations for the treatment of secretory disorders
SG11202000612TA (en) Methods and compositions for the treatment of melanoma
EP3131635A4 (en) Compositions and methods for the treatment or prevention of neurodegenerative disorders
DK3313207T3 (en) Compositions and methods for the treatment of malnutrition
IL265242B (en) Compounds for the treatment of hypertension and/or fibrosis
EP3104940A4 (en) Compositions and methods for the prevention and/or treatment of schistosomiasis
HK40006311A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders